TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
10,477
|
4,971
|
8,198 |
Financial expenses |
3,280
|
2,973
|
1,321 |
Earnings before taxes |
-83,767
|
-58,750
|
-12,170 |
Total assets |
157,075
|
141,674
|
34,465 |
Current assets |
104,293
|
105,799
|
2,190 |
Current liabilities |
39,707
|
21,001
|
15,038 |
Equity capital |
98,886
|
106,851
|
-6,053 |
- share capital |
24,451
|
25,723
|
24,349 |
Employees (average) |
10
|
6
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
63.0%
|
75.4%
|
-17.6% |
Turnover per employee |
1,048
|
828
|
1,640 |
Profit as a percentage of turnover |
-799.5%
|
-1181.9%
|
-148.5% |
Return on assets (ROA) |
-51.2%
|
-39.4%
|
-31.5% |
Current ratio |
262.7%
|
503.8%
|
14.6% |
Return on equity (ROE) |
-84.7%
|
-55.0%
|
201.1% |
Change turnover |
5,752
|
-3,690 | |
Change turnover % |
122%
|
-43% | |
Chg. No. of employees |
4
|
1 | |
Chg. No. of employees % |
67%
|
20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.